{
  "abstract": "SUMMARY: A critical driver of type 2 diabetes is the failure of insulin-secreting β cells due to dysfunction and loss of cell number or identity. The signaling pathways that trigger these events remain unclear. Here, we identify an epithelial-to-mesenchymal (EMT)-like program that is activated in β cells to promote their loss with type 2 diabetes. This program is initiated in human and mouse β cells by the EMT transcription factor Yap1. While this protein is normally not present in β cells, Yap1 becomes upregulated in response to oxidative stress and impaired mitochondrial function. Chemical inhibition of Yap1 in islets reverses EMT-like activation while its overexpression in cells triggered the appearance of mesenchymal-like vimentin+ cells. Functionally, blocking Yap1 in isolated islets and in mice improves insulin secretion and alleviates diabetes. Taken together, we have identified a novel pathway of β-cell failure during type 2 diabetes, revealing a potential target for future diabetes treatment.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Medicine, Division of Endocrinology, Columbia University, New York, NY, USA",
    "Naomi Berrie Diabetes Center, Columbia University, New York, NY, USA",
    "Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA",
    "Present address: Department of Medicine, Division of Digestive Diseases, Emory University, Atlanta, GA, USA",
    "Lead contact",
    "Present address: Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Weill Center for Metabolic Health, Weill Cornell Medicine, New York, NY, USA",
    "Forkhead BioTherapeutics, Inc., New York, NY, USA"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0,
        1,
        2,
        3,
        4
      ],
      "name": "Wendy M. McKimpson"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Nehan Hoque"
    },
    {
      "affs": [
        2,
        3
      ],
      "name": "Matthew Barter"
    },
    {
      "affs": [
        0,
        1,
        5
      ],
      "name": "Jinsook Son"
    },
    {
      "affs": [
        6
      ],
      "name": "April Y. Lee"
    },
    {
      "affs": [
        0,
        1
      ],
      "name": "Hitoshi Watanabe"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/42wgvb4ge9t4j.bib",
  "cited_by": 0,
  "doi": "10.1016/j.celrep.2026.117596",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13758910/",
  "id": "42wgvb4ge9t4j",
  "issns": [
    "2211-1247"
  ],
  "landing_url": "https://doi.org/10.1016/j.celrep.2026.117596",
  "language": "en",
  "licence": "CC-BY-NC-ND-4.0",
  "licence_label": "CC BY-NC-ND 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Article"
    ],
    [
      "openalex",
      "2712|Pancreatic function and diabetes"
    ]
  ],
  "openalex": "W7166513236",
  "pdf_url": null,
  "pmcid": "PMC13758910",
  "pmid": "42378086",
  "published": "2026-06-30",
  "publisher": null,
  "ris": "https://research.draconitic.com/paper/42wgvb4ge9t4j.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:33Z",
      "native_id": "PMC13758910",
      "source": "pmc",
      "url": "https://doi.org/10.1016/j.celrep.2026.117596"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2712|Pancreatic function and diabetes",
      "subfield": "endocrinology-metabolism"
    }
  ],
  "title": "Activation of a Yap1-mesenchymal-like program in β-cells during diabetes",
  "title_text": "Activation of a Yap1-mesenchymal-like program in β-cells during diabetes",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:33Z",
  "url": "https://research.draconitic.com/paper/42wgvb4ge9t4j",
  "venue": "Cell reports",
  "versions": []
}